4U44
MAP4K4 in complex with inhibitor (compound 16)
4U44 の概要
エントリーDOI | 10.2210/pdb4u44/pdb |
関連するPDBエントリー | 4U3Y 4U3Z 4U40 4U41 4U42 4U43 4U45 |
分子名称 | Mitogen-activated protein kinase kinase kinase kinase 4, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, SODIUM ION, ... (5 entities in total) |
機能のキーワード | kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
由来する生物種 | Homo sapiens (Human) |
細胞内の位置 | Cytoplasm : O95819 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 76245.70 |
構造登録者 | |
主引用文献 | Wang, L.,Stanley, M.,Boggs, J.W.,Crawford, T.D.,Bravo, B.J.,Giannetti, A.M.,Harris, S.F.,Magnuson, S.R.,Nonomiya, J.,Schmidt, S.,Wu, P.,Ye, W.,Gould, S.E.,Murray, L.J.,Ndubaku, C.O.,Chen, H. Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. Bioorg.Med.Chem.Lett., 24:4546-4552, 2014 Cited by PubMed Abstract: MAP4K4 has been shown to regulate key cellular processes that are tied to disease pathogenesis. In an effort to generate small molecule MAP4K4 inhibitors, a fragment-based screen was carried out and a pyrrolotriazine fragment with excellent ligand efficiency was identified. Further modification of this fragment guided by X-ray crystal structures and molecular modeling led to the discovery of a series of promising compounds with good structural diversity and physicochemical properties. These compounds exhibited single digit nanomolar potency and compounds 35 and 44 achieved good in vivo exposure. PubMed: 25139565DOI: 10.1016/j.bmcl.2014.07.071 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.43 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード